ArrowMark Colorado Holdings’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.33M | Sell |
770,225
-127,721
| -14% | -$1.22M | 0.13% | 159 |
|
|
2025
Q1 | $9.39M | Sell |
897,946
-34,285
| -4% | -$359K | 0.15% | 130 |
|
|
2024
Q4 | $22M | Buy |
932,231
+32,041
| +4% | +$755K | 0.3% | 89 |
|
|
2024
Q3 | $32.3M | Sell |
900,190
-19,226
| -2% | -$691K | 0.41% | 69 |
|
|
2024
Q2 | $32.4M | Buy |
919,416
+537,000
| +140% | +$19M | 0.39% | 73 |
|
|
2024
Q1 | $10.9M | Hold |
382,416
| – | – | 0.12% | 137 |
|
|
2023
Q4 | $5.09M | Hold |
382,416
| – | – | 0.06% | 203 |
|
|
2023
Q3 | $3.43M | Hold |
382,416
| – | – | 0.04% | 210 |
|
|
2023
Q2 | $4.3M | Buy |
382,416
+107,252
| +39% | +$1.21M | 0.05% | 207 |
|
|
2023
Q1 | $3.17M | Hold |
275,164
| – | – | 0.04% | 214 |
|
|
2022
Q4 | $3.19M | Hold |
275,164
| – | – | 0.04% | 216 |
|
|
2022
Q3 | $3.5M | Buy |
275,164
+106,664
| +63% | +$1.35M | 0.04% | 232 |
|
|
2022
Q2 | $1.16M | Hold |
168,500
| – | – | 0.01% | 262 |
|
|
2022
Q1 | $1.62M | Hold |
168,500
| – | – | 0.01% | 274 |
|
|
2021
Q4 | $2M | Hold |
168,500
| – | – | 0.02% | 268 |
|
|
2021
Q3 | $2.74M | Hold |
168,500
| – | – | 0.02% | 272 |
|
|
2021
Q2 | $3.55M | Buy |
168,500
+68,500
| +69% | +$1.44M | 0.03% | 257 |
|
|
2021
Q1 | $1.55M | Hold |
100,000
| – | – | 0.01% | 289 |
|
|
2020
Q4 | $2.1M | Sell |
100,000
-100,000
| -50% | -$2.1M | 0.02% | 263 |
|
|
2020
Q3 | $4.04M | Buy |
+200,000
| New | +$4.04M | 0.04% | 229 |
|